Image

Global Sanger Sequencing Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Aug 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • Aug 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Sanger Sequencing Market, By Application (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, and Others), Sequencing (Shotgun Sequencing, Targeted Gene Sequencing, Others), Laboratory (Wet Labs, Dry Labs), Research (In-House, Outsourced), End Use (Academic and Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals and Clinics) – Industry Trends and Forecast to 2029.

Sanger Sequencing Market

Sanger Sequencing Market Analysis and Size

An oligonucleotide sequencing primer that binds to the DNA next to the region of interest is used in Sanger sequencing to focus on a particular area of the template DNA. W Sanger sequencing uses chemical replicas of the four DNA nucleotides to determine the sequence. Dideoxyribonucleotides (ddNTPs) are these analogues, which lack the 3' hydroxyl group necessary for the 5' to 3' elongation of a DNA polynucleotide chain.

Data Bridge Market Research analyses that the sanger sequencing market which was USD 1.92 billion in 2021, would rocket up to USD 7.47 billion by 2029, and is expected to undergo a CAGR of 18.50% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Sanger Sequencing Market Scope and Segmentation      

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Application (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, and Others), Sequencing (Shotgun Sequencing, Targeted Gene Sequencing, Others), Laboratory (Wet Labs, Dry Labs), Research (In-House, Outsourced), End Use (Academic and Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals and Clinics)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Thermo Fisher Scientific Inc (U.S.), Source BioScience (U.K.), GenScript (U.S.), LGC Limited (U.K.), CeMIA (U.S.), Quintara Biosciences (U.S.), GenHunter Corporation (U.S.), GENEWIZ (U.S.), Nucleics (U.K.), SciGenom Labs Pvt. Ltd (India), Microsynth AG (Switzerland), Eurofins Scientific (Luxembourg), LGC Limited (U.K.), Fasteris SA (Switzerland) and StarSEQ GmbH (Germany)

Market Opportunities

  • Growing demand for affordable genotyping services
  • Growing need for pharmacogenomics in the development and advancement of medications

Market Definition

The sanger technique of DNA sequencing relies on the random incorporation of chain-terminating dideoxynucleotides by DNA polymerase during in vitro DNA replication and uses electrophoresis. However, for smaller-scale initiatives and for validating the outcomes of deep sequencing, the sanger approach is still widely used. It can still create DNA sequence reads of more than 500 nucleotides and maintain accuracy levels around 99.99 percent, giving it an edge over short-read sequencing methods (like Illumina).

Sanger Sequencing Market Dynamics

Drivers

  • Technological advancements

The market for Sanger's sequencing services is expanding due to technological developments in sequencing methods, benefits of Sanger's sequencing, and an increase in genome mapping initiatives. Additionally, sequencing applications and R&D expenditure boost have added to the market's expansion.

  • Research and development (R&D) activities

The increased attention that vendors are paying to developing economies like China, India, and Southeast Asia is anticipated to promote market expansion. The market is expected to experience significant growth in the near future as a result of rising R&D spending and a boom in sanger sequencing applications.

  • Rise in genetic illness

The expanding use of genetic testing on vertebrates and plants, other factors influencing the market's growth include the rising prevalence and familiarity of genetic illnesses and tailored medicine. During the forecast period of 2022 to 2029, a few factors have the potential to propel market expansion.

Opportunities

A number of factors, including growing demand for affordable genotyping services, declining sequencing rates, technological advancements, and the growing need for pharmacogenomics in the development and advancement of medications, the Sanger sequencing market is predicted to grow at a healthy rate.

Restraints/Challenges

In addition to the lack of compensation due to the strict restrictions for next-generation sequencing research, the lack of skilled professionals or one might even say a still-evolving business, can operate as a restraint on the market's growth.

This sanger sequencing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the sanger sequencing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Sanger Sequencing Market

The COVID-19 epidemic had an severe negative impact on society and the economy. The pandemic has impacted numerous organisations' supply chains and value chains. The market for sanger sequencing is typical. On the basis of the entire industry, taking into account both the demand side and supply side viewpoints, the impact of the COVID-19 pandemic will be examined.

Global Sanger Sequencing Market Scope

The sanger sequencing market is segmented on the basis of application, sequencing, laboratory, research, and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

  • Diagnostics
  • Biomarkers
  • Cancer
  • Reproductive Health
  • Personalized Medicine
  • Forensics
  • Others

 Sequencing

  • Shotgun Sequencing
  • Targeted Gene Sequencing
  • Others

 Laboratory

  • Wet Labs
  • Dry Labs

 Research

  • In-House
  • Outsourced

 End Use

  • Academic
  • Government Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Hospitals
  • Clinics

Sanger Sequencing Market Regional Analysis/Insights

The sanger sequencing market is analysed and market size insights and trends are provided by country, application, sequencing, laboratory, research, and end use as referenced above.

The countries covered in the sanger sequencing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the sanger sequencing market due to the rising number of geriatric population and innovative medical technology adoption.

Asia-Pacific (APAC) predicted to observe notable germination in the forecast period of 2022 to 2029, due to an expansion in research and development expenditure and a rise in the utilization of Sanger sequencing.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Sanger Sequencing Market Share Analysis

The sanger sequencing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to sanger sequencing market.

Some of the major players operating in the sanger sequencing market are:

  • Thermo Fisher Scientific Inc (U.S.)
  • Source BioScience (U.K.)
  • GenScript (U.S.)
  • LGC Limited (U.K.)
  • CeMIA (U.S.),
  • Quintara Biosciences (U.S.)
  • GenHunter Corporation (U.S.)
  • GENEWIZ (U.S.), Nucleics (U.K.)
  • SciGenom Labs Pvt. Ltd (India)
  • Microsynth AG (Switzerland)
  • Eurofins Scientific (Luxembourg)
  • LGC Limited (U.K.)
  • Fasteris SA (Switzerland)
  • StarSEQ GmbH (Germany)


SKU-
Why Choose Us


Frequently Asked Questions

The sanger sequencing market value is projected USD 7.47 billion by 2029.
The sanger sequencing market is projected to grow at a CAGR of 18.50% during the forecast period of 2022-2029.
On the basis of application, the Sanger Sequencing Market is segmented into Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, and Others.
The major countries covered in the Sanger Sequencing Market are Thermo Fisher Scientific Inc (U.S.), Source BioScience (U.K.), GenScript (U.S.), LGC Limited (U.K.), CeMIA (U.S.), Quintara Biosciences (U.S.), GenHunter Corporation (U.S.), GENEWIZ (U.S.), Nucleics (U.K.), SciGenom Labs Pvt. Ltd (India), Microsynth AG (Switzerland), Eurofins Scientific (Luxembourg), LGC Limited (U.K.), Fasteris SA (Switzerland) and StarSEQ GmbH (Germany).